What the publication found
The 2023 North American Menopause Society position statement evaluated nonhormonal treatments for vasomotor symptoms, including hot flashes. It recommended cognitive behavioral therapy, clinical hypnosis, certain SSRIs and SNRIs, gabapentin, and fezolinetant on Level I evidence. Oxybutynin also received a recommendation, with evidence graded Level I–II. The statement did not recommend supplements or herbal remedies for treating these symptoms. These recommendations concern relief of vasomotor symptoms; they do not establish that every option addresses every symptom of menopause. Source: The 2023 nonhormone therapy position statement of The North American Menopause Society.
What the evidence cannot establish
This is a professional evidence review, not a trial comparing all options in one population. Its recommendations date to 2023 and are not an exhaustive list of treatments available in 2026. A favorable evidence grade does not establish suitability for a particular patient. Current prescribing information and individual safety considerations still need review. Source: The 2023 nonhormone therapy position statement of The North American Menopause Society.
Begin with the problem you want to solve
Before a visit, write down which episodes interrupt sleep, work, or everyday activities. Include how often they happen and what you hope will change. If you have tried a product, record its name and your experience rather than simply writing that it did not work. This gives the conversation a concrete starting point without asking you to diagnose the cause yourself.
Compare options using the same questions
Ask about the expected benefit, how that benefit was measured, the time needed to assess a response, and the follow-up involved. Request an explanation of side effects and any monitoring before choosing an option. A treatment described as nonhormonal should receive the same careful discussion as a hormone-based treatment. Avoid treating the label as a substitute for an explanation of risks.
Preparing for a Palatine consultation
Bring your medication and supplement list and explain why you are interested in avoiding hormones. That preference is useful information for a discussion, not a reason to choose a treatment from an online list. Women’s Health Chicago is at 600 N North Ct, Suite 120, Palatine. A consultation request starts a conversation; this guide does not promise that any particular medicine will be prescribed.
Questions to bring to your visit
- Which option has evidence for the symptom that bothers me most?
- Does a newer guideline or safety update change this 2023 recommendation?
- What follow-up and costs should I understand before deciding?
Sources and further reading
- The 2023 nonhormone therapy position statement of The North American Menopause Society.Journal publication · Peer-reviewed professional consensus / evidence review. 2023
This is a patient-facing guide, not an original research publication. Prepared with AI assistance and checked against the linked sources. No clinician review is claimed. General education cannot determine which care is right for you.